Regulatory Affairs Services Provider in Ireland
Ireland has emerged as one of Europe's more significant pharmaceutical markets. The country brings together an established manufacturing base, a strong record of innovation, and a regulatory standing that gives companies a real foothold within the European Union. None of this makes market entry easy. Any company bringing a product into Ireland works within a framework rooted in European Union legislation, and the compliance expectations tied to that framework leave little margin for error.
DDReg built its regulatory affairs practice around exactly this need. The firm helps pharmaceutical companies prepare compliant submissions, move through approval, and manage the full regulatory lifecycle management of doing business in Ireland.
Drug Regulatory Authority Framework in Ireland
HPRA, or the Health Products Regulatory Authority, sits at the center of medicinal product oversight in Ireland, with a mandate that covers both public and animal health. The scope of its work is broad: registering and authorizing products, licensing imports, running GMP inspections , tracking pharmacovigilance, and policing how products are labeled and advertised once they're on shelves.
Approval isn't where HPRA's involvement ends, either. The authority tracks a product from its early clinical development all the way through its time on the market, keeping an eye on safety long after launch.
Ireland's EU membership shapes this framework in a meaningful way. Companies can pursue centralized, decentralized, or mutual recognition procedures through the European Medicines Agency and the broader EU regulatory network, so a single coordinated regulatory effort can open access to both the Irish and wider European markets.
Our HPRA Regulatory Consulting Services in Ireland
DDReg's pharmaceutical regulatory consultant in Ireland covers the full scope of market presence, from initial approval through years of ongoing compliance:
Our services include:
- Regulatory strategy and market entry planning
- Product registration and marketing authorization support
- CTD/eCTD dossier preparation, compilation, and submission
- Dossier gap analysis against local regulatory requirements
- Submission planning and tracking
- Response management for authority queries and deficiency letters
- Import licensing and regulatory documentation support
- Labeling and artwork compliance with national guidelines
- Local representative coordination and regulatory liaison
- Lifecycle management, including variations, renewals, and updates
- Regulatory intelligence and compliance monitoring
HPRA, EMA, and HSE Regulatory Pathways in Ireland with DDReg
- Getting a medicine into the Irish market means clearing two distinct stages: Marketing Authorisation, then Reimbursement Assessment. Different authorities oversee each one, and each applies its own evaluation criteria.
- Marketing Authorisation: HPRA grants approval directly in some cases; in others, it comes through the EMA's centralized EU procedures.
- The bar is the same regardless of route: the product has to prove it meets the required safety, efficacy, and quality standards before it can reach the market.
- Reimbursement Assessment: Marketing approval on its own doesn't secure public funding. Medicines seeking reimbursement go through evaluation by the National Centre for Pharmacoeconomics (NCPE) and the Health Service Executive (HSE), starting with a Rapid Review and, for more complex cases, moving into a full Health Technology Assessment before pricing and reimbursement negotiations follow.
- Between the two stages, a medicine ends up assessed twice before it reaches the public system: once for clinical merit, and again for economic justification.
Why Choose DDReg for Regulatory Affairs Partner in Ireland?
DDReg supports companies through both halves of Ireland's regulatory pathway, handling Marketing Authorisation through HPRA and EMA alongside Reimbursement Assessment through NCPE and HSE, to keep the process efficient and compliant throughout.
- End-to-End Regulatory Expertise: Managing HPRA and EMA submissions through national, decentralized, and mutual recognition procedures, with ongoing attention to evolving EU requirements.
- Reimbursement and Market Access Support: Hands-on support for NCPE Rapid Reviews and Health Technology Assessments, with submissions built around Ireland's expectations on pricing and reimbursement under the HSE.
- Integrated Regulatory Strategy: Planning approval and market access together, rather than treating them as separate efforts, narrows the gap between authorization and reimbursement.
- Document Management Standards: CTD/eCTD preparation and gap analysis follow both Irish and EU regulatory standards.
- Authority Interface Management: Responses to HPRA queries, NCPE evaluations, and HSE negotiations are structured to keep things moving and avoid unnecessary delay.
- Lifecycle Compliance Support: Support continues after approval, covering variations, renewals, and labeling updates.
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Ireland portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
